120 related articles for article (PubMed ID: 28088456)
1. Development of a Predictive Model for the Long-Term Stability Assessment of Drug-In-Adhesive Transdermal Films Using Polar Pressure-Sensitive Adhesives as Carrier/Matrix.
Chenevas-Paule C; Wolff HM; Ashton M; Schubert M; Dodou K
J Pharm Sci; 2017 May; 106(5):1293-1301. PubMed ID: 28088456
[TBL] [Abstract][Full Text] [Related]
2. Development of a Predictive Model for the Stabilizer Concentration Estimation in Microreservoir Transdermal Drug Delivery Systems Using Lipophilic Pressure-Sensitive Adhesives as Matrix/Carrier.
Chenevas-Paule C; Wolff HM; Ashton M; Schubert M; Dodou K
J Pharm Sci; 2017 May; 106(5):1371-1383. PubMed ID: 28163134
[TBL] [Abstract][Full Text] [Related]
3. Investigations on the viscoelastic performance of pressure sensitive adhesives in drug-in-adhesive type transdermal films.
Wolff HM; Irsan ; Dodou K
Pharm Res; 2014 Aug; 31(8):2186-202. PubMed ID: 24599801
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Amorphous Drug Stability Predictions Using Easily Calculated, Predicted, and Measured Parameters.
Nurzyńska K; Booth J; Roberts CJ; McCabe J; Dryden I; Fischer PM
Mol Pharm; 2015 Sep; 12(9):3389-98. PubMed ID: 26236939
[TBL] [Abstract][Full Text] [Related]
5. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
6. Hot melt extruded transdermal films based on amorphous solid dispersions in Eudragit RS PO: The inclusion of hydrophilic additives to develop moisture-activated release systems.
Albarahmieh E; Qi S; Craig DQM
Int J Pharm; 2016 Nov; 514(1):270-281. PubMed ID: 27863672
[TBL] [Abstract][Full Text] [Related]
7. Role of pressure-sensitive adhesives in transdermal drug delivery systems.
Lobo S; Sachdeva S; Goswami T
Ther Deliv; 2016; 7(1):33-48. PubMed ID: 26652621
[TBL] [Abstract][Full Text] [Related]
8. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
Roy SD; Gutierrez M; Flynn GL; Cleary GW
J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
[TBL] [Abstract][Full Text] [Related]
9. Designing and characterizing of tramadol hydrochloride transdermal patches prepared with Ficus carica fruit mucilage and povidone.
Ahad HA; Ishaq BM; Shaik M; Bandagisa F
Pak J Pharm Sci; 2016 May; 29(3):945-51. PubMed ID: 27166538
[TBL] [Abstract][Full Text] [Related]
10. Development of a drug-in-adhesive patch combining ion pair and chemical enhancer strategy for transdermal delivery of zaltoprofen: pharmacokinetic, pharmacodynamic and in vitro/in vivo correlation evaluation.
Cui H; Quan P; Zhou Z; Fang L
Drug Deliv; 2016 Nov; 23(9):3461-3470. PubMed ID: 27257038
[TBL] [Abstract][Full Text] [Related]
11. Crystallization of beta-estradiol in an acrylic transdermal drug delivery system.
Variankaval NE; Jacob KI; Dinh SM
J Biomed Mater Res; 1999 Mar; 44(4):397-406. PubMed ID: 10397943
[TBL] [Abstract][Full Text] [Related]
12. Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.
Murdande SB; Pikal MJ; Shanker RM; Bogner RH
J Pharm Sci; 2010 Mar; 99(3):1254-64. PubMed ID: 19697391
[TBL] [Abstract][Full Text] [Related]
13. Interaction between drugs and pressure-sensitive adhesives in transdermal therapeutic systems.
Kokubo T; Sugibayashi K; Morimoto Y
Pharm Res; 1994 Jan; 11(1):104-7. PubMed ID: 8140038
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
15. A novel transdermal drug delivery system based on self-adhesive Janus nanofibrous film with high breathability and monodirectional water-penetration.
Shi Y; Li Y; Wu J; Wang W; Dong A; Zhang J
J Biomater Sci Polym Ed; 2014; 25(7):713-28. PubMed ID: 24641249
[TBL] [Abstract][Full Text] [Related]
16. Eudragits: role as crystallization inhibitors in drug-in-adhesive transdermal systems of estradiol.
Kotiyan PN; Vavia PR
Eur J Pharm Biopharm; 2001 Sep; 52(2):173-80. PubMed ID: 11522483
[TBL] [Abstract][Full Text] [Related]
17. A novel method for determination of drug solubility in polymeric matrices.
Jasti BR; Berner B; Zhou SL; Li X
J Pharm Sci; 2004 Aug; 93(8):2135-41. PubMed ID: 15236460
[TBL] [Abstract][Full Text] [Related]
18. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of adhesive properties and drug-adhesive interactions for transdermal drug delivery formulations using linear solvation energy relationships.
Li J; Masso JJ; Rendon S
J Control Release; 2002 Jul; 82(1):1-16. PubMed ID: 12106972
[TBL] [Abstract][Full Text] [Related]
20. An investigation into the crystallisation behaviour of an amorphous cryomilled pharmaceutical material above and below the glass transition temperature.
Qi S; Weuts I; De Cort S; Stokbroekx S; Leemans R; Reading M; Belton P; Craig DQ
J Pharm Sci; 2010 Jan; 99(1):196-208. PubMed ID: 19492312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
